相关实验视频

Updated: Jun 3, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

血糖变量的关联与非糖尿病性败血症患者的结果:一项前性观察性研究

Prithiviraaj Prakash¹, Prayas Sethi¹, Naval Vikram¹

¹Department of Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

|January 13, 2025

概括

非糖尿病性败血症患者的血糖变化 (GV) 与更高的住院死亡率有关. 监测GV可能有助于识别针对性干预的高风险个体.

科学领域:

关键护理医学关键护理医学
内分泌学在内分泌学.
败血症研究败血症研究

背景情况:

血糖变化 (GV) 是败血症引起的失糖症的一个关键方面.
了解GV的影响对于改善败血症患者的治疗结果至关重要.
在非糖尿病性败血症患者中对GV的研究有限,特别是来自印度次大陆的患者.

研究的目的:

研究非糖尿病性败血症患者的血糖变化 (GV) 和住院死亡率之间的关联.
在这个患者队列中探索GV和住院时间 (LOS) 之间的关系.
确定测量GV在败血症管理中的潜在临床影响.

主要方法:

一项前性观察性研究,涉及80名非糖尿病性败血症患者.
每天监测血糖 (每天7次),持续14天.
在多个时间点评估GV参数 (SD,CV,MAGE) 和临床实验室数据.

主要成果:

较高的GV (SD,CV,MAGE) 与增加的住院死亡率显著相关,独立于疾病严重程度和平均葡萄糖水平.
在GV和住院时间 (LOS) 之间没有发现显著的相关性.
CV独立地与机械通风的需要有关,SD与脏替代疗法有关.

结论:

血糖变异性是非糖尿病性败血症患者住院死亡率的独立预测因素.
需要进一步的研究来确定针对GV的干预措施是否可以改善败血症的结果.
测量GV可能有助于分层死亡风险,并指导在败血症中进行密集的葡萄糖管理.

关键词:

血糖的可变性血糖的可变性死亡率死亡率死亡率没有糖尿病的人.败血症这是一种败血症.

更多相关视频

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...